192 related articles for article (PubMed ID: 28485550)
1. A history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database.
Tajik AA; Dobre D; Aguilar D; Kjekshus J; Zannad F; Dickstein K;
Eur J Heart Fail; 2017 May; 19(5):635-642. PubMed ID: 28485550
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.
Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Solomon SD; Dickstein K; Atar D; Agewall S; Girerd N;
Am Heart J; 2019 Sep; 215():83-90. PubMed ID: 31291604
[TBL] [Abstract][Full Text] [Related]
3. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.
Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N;
Int J Cardiol; 2018 Dec; 272():260-266. PubMed ID: 30144995
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P;
Eur J Heart Fail; 2015 Nov; 17(11):1144-51. PubMed ID: 26424212
[TBL] [Abstract][Full Text] [Related]
5. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
[TBL] [Abstract][Full Text] [Related]
6. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
Shah AM; Pfeffer MA; Hartley LH; Moyé LA; Gersh BJ; Rutherford JD; Lamas GA; Rouleau JL; Braunwald E; Solomon SD
Am J Cardiol; 2010 Oct; 106(7):911-6. PubMed ID: 20854949
[TBL] [Abstract][Full Text] [Related]
7. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA
Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
[TBL] [Abstract][Full Text] [Related]
8. Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative.
Stienen S; Ferreira JP; Girerd N; Duarte K; Lamiral Z; McMurray JJV; Pitt B; Dickstein K; Zannad F; Rossignol P;
Clin Res Cardiol; 2019 Nov; 108(11):1215-1225. PubMed ID: 30953180
[TBL] [Abstract][Full Text] [Related]
9. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Stephenson K; Skali H; McMurray JJ; Velazquez EJ; Aylward PG; Kober L; Van de Werf F; White HD; Pieper KS; Califf RM; Solomon SD; Pfeffer MA
Heart Rhythm; 2007 Mar; 4(3):308-13. PubMed ID: 17341394
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Lam CS; McEntegart M; Claggett B; Liu J; Skali H; Lewis E; Køber L; Rouleau J; Velazquez E; Califf R; McMurray JJ; Pfeffer M; Solomon S
Eur J Heart Fail; 2015 Mar; 17(3):301-12. PubMed ID: 25655011
[TBL] [Abstract][Full Text] [Related]
12. Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative.
Ferreira JP; Duarte K; Pfeffer MA; McMurray JJV; Pitt B; Dickstein K; Zannad F; Rossignol P;
Eur J Heart Fail; 2018 Feb; 20(2):323-331. PubMed ID: 29314455
[TBL] [Abstract][Full Text] [Related]
13. Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Bauersachs J; Pitt B; Fay R; Ambrosio G; Solomon SD; Dickstein K; Zannad F
Clin Res Cardiol; 2017 Sep; 106(9):722-733. PubMed ID: 28455597
[TBL] [Abstract][Full Text] [Related]
14. Editor's Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction.
Rossello X; Ferreira JP; McMurray JJ; Aguilar D; Pfeffer MA; Pitt B; Dickstein K; Girerd N; Rossignol P; Zannad F;
Eur Heart J Acute Cardiovasc Care; 2019 Apr; 8(3):231-241. PubMed ID: 30259764
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
Anavekar NS; Skali H; Bourgoun M; Ghali JK; Kober L; Maggioni AP; McMurray JJ; Velazquez E; Califf R; Pfeffer MA; Solomon SD
Am J Cardiol; 2008 Mar; 101(5):607-12. PubMed ID: 18308007
[TBL] [Abstract][Full Text] [Related]
16. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.
Shah AM; Hung CL; Shin SH; Skali H; Verma A; Ghali JK; Køber L; Velazquez EJ; Rouleau JL; McMurray JJ; Pfeffer MA; Solomon SD
Am Heart J; 2011 Oct; 162(4):685-91. PubMed ID: 21982661
[TBL] [Abstract][Full Text] [Related]
17. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis.
Høfsten DE; Løgstrup BB; Møller JE; Pellikka PA; Egstrup K
JACC Cardiovasc Imaging; 2009 May; 2(5):592-9. PubMed ID: 19442946
[TBL] [Abstract][Full Text] [Related]
18. Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative.
Agewall S; Tjessem LH; Rossignol P; Zannad F; Atar D; Lamiral Z; Machu JL; Dickstein K; Kjekshus J; von Lueder TG; Girerd N;
Int J Cardiol; 2017 Dec; 249():274-281. PubMed ID: 28964557
[TBL] [Abstract][Full Text] [Related]
19. Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study.
Lee YB; Han K; Kim B; Lee SE; Jun JE; Ahn J; Kim G; Jin SM; Kim JH
Cardiovasc Diabetol; 2019 Nov; 18(1):157. PubMed ID: 31733656
[TBL] [Abstract][Full Text] [Related]
20. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
